Samuel Bates Martin - SVP AND CFO at Celldex Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp And Cfo
Stock Symbol
CLDX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Samuel Bates Martin since 10/18/2024

Holdings reported by Samuel Bates Martin for Celldex Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 28.1K $996K $35.42 Jun 14, 2024 Direct
Incentive Stock Option (right to buy) 81K Jun 5, 2025 Direct Common Stock

Transactions reported by Samuel Bates Martin for Celldex Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.